Navigation Links
Atherotech Adds New Cardiometabolic Tests Amid Strong 2009 Growth
Date:8/12/2009

BIRMINGHAM, Ala., Aug. 12 /PRNewswire/ -- Atherotech, Inc., developer of the VAP Cholesterol Test, has announced the addition of two new cardiometabolic tests as it continues to grow its cardiodiagnostic business.

The company has added the PLAC Test for identification of increased heart attack and stroke risk, and the Cystatin C test as an early, sensitive marker for chronic kidney disease. The tests expand Atherotech's cardiovascular disease and metabolic panels that complement the company's advanced lipid profile, the VAP (Vertical Auto Profile) Test.

"We're seeing increased demand and experiencing strong growth in our business," said Atherotech President and CEO Mike Mullen, "and the marketplace is responding positively to our offering. Look for Atherotech to continue adding to the value of our core VAP lipid test by giving physicians and cardiology practices a single source for multiple cardiovascular disease and metabolic test panels."

Atherotech is privately held and doesn't disclose specific figures, but Mullen said that he expects revenues for his company to increase more than 20 percent in 2009 compared to last year, with profits increasing as well. Mullen believes the VAP lipid test is the centerpiece for this growth.

"We're providing valuable and clinically relevant information at a low cost, which leads to accurate diagnosis, targeted treatment and positive outcomes. This is a positive development for all stakeholders within our current health care environment, including managed care payers, patients, doctors and other health care providers," explained Mullen.

Cardiometabolic and genetic tests already available from Atherotech include C-Reactive Protein (hsCRP), apoE genotype, NT-proBNP, homocysteine, creatinine, creatine kinase (CK), HbA1c, TSH, ALT, AST, urea nitrogen (BUN), glucose, vitamin D and insulin. Cardiometabolic test panels can be ordered individually or bundled as part of a custom risk profile that also includes the VAP expanded cholesterol profile.

The VAP Cholesterol Test provides physician practices, researchers and health care providers with direct measurement of LDL, HDL and all relevant subclasses, and includes non-HDL, apoB, and emerging risk factors such as Lp(a), remnants and small dense LDL. The VAP Test is the only single cholesterol test that routinely reports apoAI, apoB and the apoB/apoAI ratio.

For more information call 877.901.8510 or visit www.thevaptest.com.

About Atherotech, Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. It is the only advanced lipid profile that routinely reports all three lipoprotein parameters considered necessary by the American Diabetes Association and American College of Cardiology expert consensus guidelines. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit www.thevaptest.com.


'/>"/>
SOURCE Atherotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Atherotech to Exhibit The VAP Test at ADA 2008 Meeting in San Francisco
2. CardioCareLive.com, First Ever Online Cardiometabolic Conference, Revolutionizes Continuing Medical Education for Cardiovascular Healthcare Professionals
3. CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
4. Noninvasive Medical Technologies to Exhibit at CardioCareLive - A Premier Cardiometabolic Conference
5. Teens May Not Benefit from Pap Tests
6. Orlando Regional Medical Center (ORMC) Implements PNA FISH(R) Tests to Help Provide Better Care for Patients with Bloodstream Infections
7. Grupo Salinas, Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti-Litter and Recycling Contests
8. Most neuropsychological tests dont tell Alzheimers disease from vascular dementia
9. Buyer Beware! Know What Youre Getting When You Buy Online Genetic Tests
10. Larger hospital units have lower miscarriage rates after invasive pregnancy tests
11. Despite More Tests, Some Arent Getting Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & Associates, a ... communities in North-Central West Virginia, is embarking on a cooperative charity effort with ... area. , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for ...
(Date:8/18/2017)... ... 2017 , ... The Brian Gifford Agency, an Indiana-based firm providing asset protection ... Campagna Academy in a charity drive to provide for at-risk children and teens in ... Academy is a nonprofit organization that has offered critical programs to at-risk and foster ...
(Date:8/18/2017)... ... 2017 , ... “Emotions are sacred, valid, honored, encouraged. This is the memo ... Generation Mindful. To help change the mindset of parents and educators from punitive to ... the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and fully funded in ...
(Date:8/18/2017)... ... 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the body of ... its product now available through Jet.com. , After 25 years of development, the ... is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having ...
(Date:8/18/2017)... ... ... “Our Mountains to Climb: A Journey of Love and Faith Through Trials”: ... faith they shared to overcome struggles in life. “Our Mountains to Climb: A Journey ... Corcoran, a retired teacher and happily married since 1999; the author’s personal experiences drive ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... , August 17, 2017 DarioHealth ... Company with mobile health and big data solutions, ... agreements with domestic and non-U.S. investors for the ... and shares of the Company,s newly designated Series ... offerings. The Company expects to conduct a closing ...
(Date:8/15/2017)... HOUSTON , Aug. 15, 2017   Mostyn Law ... in Houston, Texas . The Mostyn Law ... the past 2 years. That is why Mostyn Law ... Texas to show its appreciation. Blood supplies ... to fall 5% short of hospital needs in August. That is ...
(Date:8/15/2017)... Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of the drug ... in the beginning stages of an IPO. The ... with the average cost of a prescription epilepsy drug being $450.00-$1200.00 for ... AXIUM PHARMACEUTICALS, INC ... Another staggering figure is the fact that Americans spent ...
Breaking Medicine Technology: